CompletedObservationalLast updated May 4, 2021

A Comparison of Different Fecal Occult Blood Test for Colorectal Cancer Screening

A Comparison of Quantitative Fecal Immunochemical Test and Qualitative Fecal Occult Blood Test for Colorectal Cancer Screening in Medium and High Risk Screening Population

Overview

ClinicalTrials.gov ID: NCT04454099
Lead Sponsor: Shandong UniversityOTHER
Brief Summary: Colorectal cancer is a leading cause of cancer-related morbidity and mortality. CRC-related death can be prevented through fecal occult blood test screening. Because of economic and high sensitivity, fecal immunochemical test is recommended for screening population of CRC. The purpose of this study is to compare the accuracy of 4 different fecal occult blood testing in medium and high risk screening population in Chinese.

Status

Overall Status: Completed
Start Date: Jul 1, 2020Actual
Primary Completion Date: Mar 18, 2021Actual
Completion Date: Mar 18, 2021Actual

Study Record Dates

First Submitted: Jun 9, 2020
First Submitted that Met QC Criteria: Jun 26, 2020
First Posted: Jul 1, 2020Actual
Last Update Submitted that Met QC Criteria: May 3, 2021
Last Update Posted: May 4, 2021Actual
Last Verified: May 2021

NCT01075633Completed

Colorectal Cancer Screening in Familiar-Risk Population: Immunochemical Fecal Occult Blood Testing Versus Colonoscopy

NCT01998009Completed

Study of In-home Tests for Colorectal Cancer

NCT04473677Completed

A New Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma

NCT02491593Completed

Quantitative Immunochemical Fecal Occult Blood Test in Symptomatic Patients

NCT03411707Unknown status

Multiple Screening Methods for the Detection of Chinese Colorectal Advanced Adenomatous Polyps and Cancer

NCT01251666Completed

Comparison of Hemoccult, Magstream and OC-Sensor Faecal Occult Blood Tests in Colorectal Cancer Screening